Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
¿Quién es el CEO de Sihuan Pharmaceutical Holdings Group Ltd?
Dr. Weicheng Guo es el Executive Deputy Chairman of the Board de Sihuan Pharmaceutical Holdings Group Ltd, se unió a la empresa desde 2006.
¿Qué tal es el rendimiento del precio de la acción SHPHY?
El precio actual de SHPHY es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Sihuan Pharmaceutical Holdings Group Ltd?
Sihuan Pharmaceutical Holdings Group Ltd pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Sihuan Pharmaceutical Holdings Group Ltd?
La capitalización bursátil actual de Sihuan Pharmaceutical Holdings Group Ltd es $0
¿Es Sihuan Pharmaceutical Holdings Group Ltd una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Sihuan Pharmaceutical Holdings Group Ltd, incluyendo 3 fuerte compra, 2 compra, 1 mantener, 0 venta, y 3 fuerte venta
